The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Open accessAbstract
Purpose: We review recent advances in the biologic understanding and treatment of childhood acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), identify therapeutically challenging subgroups, and suggest future directions of research. Methods: A review of English literature on childhood acute leukemias from the past 5 years was performed. Results: Contemporary treatments have resulted in 5-year event-free survival rates of approximately 80% for childhood ALL and almost 60% for pediatric AML. The advent of high-resolution genome-wide analyses has provided new insights into leukemogenesis and identified many novel subtypes of leukemia. Virtually all ALL and the vast majority of AML cases can be classified according to specific genetic abnormalities. Cooperative mutations involved in cell differentiation, cell cycle regulation, tumor suppression, drug responsiveness, and apoptosis have also been identified in many cases. The development of new formulations of existing drugs, molecularly targeted therapy, and immunotherapies promises to further advance the cure rates and improve quality of life of patients. Conclusion: The application of new high-throughput sequencing techniques to define the complete DNA sequence of leukemia and host normal cells and the development of new agents targeted to leukemogenic pathways promise to further improve outcome in the coming decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · cited 1×
“Analysis of the second case of cytogenetically normal AML revealed 12 mutations in annotated protein-coding genes or regulatory RNAs and 52 mutations in noncoding regions of the genome.(87) Four genes, NPM1, NRAS, IDH1, and a conserved region on chromosome 10, were found in at least one additional sample of 180 adult…”
BackgroundTreatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Self-citationGenome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
Self-citationDNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D., Dunford-Shore, B. H., McGrath, S., Hickenbotham, M., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,422
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationPui, C.-H., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,185
Self-citationTumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Bargou, R., Leo, E., Zugmaier, G., Klinger, M., Goebeler, M., Knop, S., Noppeney, R., Viardot, A., Hess, G., Schuler, M., et al. (2008) · Science · doi:10.1126/science.1158545 · Cited by 1,078
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072 · cited 1×
“Genetic Determinants of High-Risk B-Cell Precursor ALL In Philadelphia chromosome–positive ALL with constitutively active BCR-ABL1 tyrosine kinase, IKZF1 (encoding the lymphoid transcription factor IKAROS) is deleted in approximately 80% of the cases.(51) Interestingly, there is a high-risk subgroup of BCR-ABL1– negat…”
BackgroundSelf-citationEarly T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Self-citationSanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Den Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.020 · Cited by 833
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G., Fielding, A. K., Burnett, A. K., Chopra, R., Wiernik, P. H., Foroni, L., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116582 · Cited by 778
Marcucci, G., Maharry, K., Wu, Y.-Z., Radmacher, M. D., Mrózek, K., Margeson, D., Holland, K. B., Whitman, S. P., Becker, H., Schwind, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3730 · Cited by 763
Schultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2514 · Cited by 701
Self-citationPaschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 663
Imai, C., Iwamoto, S., & Campana, D. (2005) · Blood · doi:10.1182/blood-2004-12-4797 · Cited by 659
Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi, L., LeBlanc, T., Szczepanski, T., Ferster, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61126-x · Cited by 652
Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
Mullighan, C. G., Collins-Underwood, J. R., Phillips, L. A. A., Loudin, M. G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R. C., Willman, C. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.469 · Cited by 623
Self-citationChromosome translocations and covert leukemic clones are generated during normal fetal development
Mori, H., Colman, S. M., Xiao, Z., Ford, A. M., Healy, L. E., Donaldson, C., Hows, J. M., Navarrete, C., & Greaves, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112218799 · Cited by 615
Boissel, N., Auclerc, M.-F., Lhéritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.-M., Gabert, J., Fegueux, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.053 · Cited by 608
Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P., Taub, J., Pounds, S., Razzouk, B. I., Lacayo, N. J., Cao, X., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70090-5 · Cited by 584
Self-citationHarvey, R. C., Mullighan, C. G., Chen, I.-M., Wharton, W., Mikhail, F. M., Carroll, A. J., Kang, H., Liu, W., Dobbin, K. K., Smith, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245944 · Cited by 574
Self-citationJAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562
Self-citationStock, W., La, M., Sanford, B., Bloomfield, C. D., Vardiman, J. W., Gaynon, P., Larson, R. A., & Nachman, J. (2008) · Blood · doi:10.1182/blood-2008-01-130237 · Cited by 534
Möricke, A., Zimmermann, M., Reiter, A., Henze, G., Schrauder, A., Gadner, H., Ludwig, W. D., Ritter, J., Harbott, J., Mann, G., et al. (2010) · Leukemia · doi:10.1038/leu.2009.257 · Cited by 520
Germline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
Self-citationPapaemmanuil, E., Hosking, F. J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., Kinsey, S. E., Lightfoot, T., Roman, E., Irving, J. A. E., et al. (2009) · Nature Genetics · doi:10.1038/ng.430 · Cited by 482
The leukemic stem cell niche: current concepts and therapeutic opportunities
Lane, S. W., Scadden, D. T., & Gilliland, D. G. (2009) · Blood · doi:10.1182/blood-2009-01-202606 · Cited by 461
Balgobind, B. V., Raimondi, S. C., Harbott, J., Zimmermann, M., Alonzo, T. A., Auvrignon, A., Beverloo, H. B., Chang, M., Creutzig, U., Dworzak, M. N., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215152 · Cited by 445
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Gutierrez, A., Sanda, T., Grebliunaite, R., Carracedo, A., Salmena, L., Ahn, Y., Dahlberg, S., Neuberg, D., Moreau, L. A., Winter, S. S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206722 · Cited by 437
Moghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V. K., Lipshultz, S. E., et al. (2007) · Blood · doi:10.1182/blood-2006-06-027714 · Cited by 403
Pui, C.-H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., Silverman, L. B., Biondi, A., Harms, D. O., Vilmer, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 399
Self-citationClinical implications of FLT3 mutations in pediatric AML
Meshinchi, S., Alonzo, T. A., Stirewalt, D. L., Zwaan, M., Zimmerman, M., Reinhardt, D., Kaspers, G. J. L., Heerema, N. A., Gerbing, R., Lange, B. J., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009233 · Cited by 395
Self-citationSchnittger, S., Kohl, T. M., Haferlach, T., Kern, W., Hiddemann, W., Spiekermann, K., & Schoch, C. (2006) · Blood · doi:10.1182/blood-2005-04-1466 · Cited by 380
Cairoli, R. (2006) · Blood · doi:10.1182/blood-2005-09-3640 · Cited by 375
Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX
(2004) · Annals of Hematology · doi:10.1007/s00277-004-0850-2 · Cited by 365
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Söderhäll, S., Taskinen, M., & On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010) · Leukemia · doi:10.1038/leu.2009.251 · Cited by 365
Treviño, L. R., Shimasaki, N., Yang, W., Panetta, J. C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K. M., Pui, C.-H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4156 · Cited by 349
Self-citationHertzberg, L., Vendramini, E., Ganmore, I., Cazzaniga, G., Schmitz, M., Chalker, J., Shiloh, R., Iacobucci, I., Shochat, C., Zeligson, S., et al. (2010) · Blood · doi:10.1182/blood-2009-08-235408 · Cited by 346
Schnittger, S., Kern, W., Tschulik, C., Weiss, T., Dicker, F., Falini, B., Haferlach, C., & Haferlach, T. (2009) · Blood · doi:10.1182/blood-2009-03-213389 · Cited by 330
de Bont, J. M., Holt, B. V. D., Dekker, A. W., van der Does-van den Berg, A., Sonneveld, P., & Pieters, R. (2004) · Leukemia · doi:10.1038/sj.leu.2403538 · Cited by 323
Berg, S. L., Blaney, S. M., Devidas, M., Lampkin, T. A., Murgo, A., Bernstein, M., Billett, A., Kurtzberg, J., Reaman, G., Gaynon, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.426 · Cited by 318
Silverman, L. B., Stevenson, K. E., O'Brien, J. E., Asselin, B. L., Barr, R. D., Clavell, L., Cole, P. D., Kelly, K. M., Laverdiere, C., Michon, B., et al. (2010) · Leukemia · doi:10.1038/leu.2009.253 · Cited by 316
Leukaemogenesis: more than mutant genes
Chen, J., Odenike, O., & Rowley, J. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2765 · Cited by 311
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., & Downing, J. R. (2008) · Blood · doi:10.1182/blood.v112.11.429.429 · Cited by 309
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304
Self-citationTreatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
Gibson, B. E. S., Wheatley, K., Hann, I. M., Stevens, R. F., Webb, D., Hills, R. K., De Graaf, S. S. N., Harrison, C. J., & for the United Kingdom Childhood Leukaemia Working Party, A. T. D. C. O. G. (2005) · Leukemia · doi:10.1038/sj.leu.2403924 · Cited by 303
Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.-D., Tolle, G., Happich, M., Muckenthaler, M. U., & Kulozik, A. E. (2006) · Blood · doi:10.1182/blood-2005-12-4956 · Cited by 293
Gaynon, P. S., Angiolillo, A. L., Carroll, W. L., Nachman, J. B., Trigg, M. E., Sather, H. N., Hunger, S. P., Devidas, M., & for the Children's Oncology Group, A. C. (2010) · Leukemia · doi:10.1038/leu.2009.262 · Cited by 293
Self-citationPui, C. H., Pei, D., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., Campana, D., Kun, L. E., Jeha, S., et al. (2010) · Leukemia · doi:10.1038/leu.2009.252 · Cited by 293
Self-citationLange, B. J., Smith, F. O., Feusner, J., Barnard, D. R., Dinndorf, P., Feig, S., Heerema, N. A., Arndt, C., Arceci, R. J., Seibel, N., et al. (2008) · Blood · doi:10.1182/blood-2007-04-084293 · Cited by 274
Self-citationPrinciples and Practice of Pediatric Oncology
Amendola, B. E. (1990) · American Journal of Clinical Oncology · doi:10.1097/00000421-199002000-00026 · Cited by 274
The Molecular Basis of Leukemia
Gilliland, D. G., Jordan, C. T., & Felix, C. A. (2004) · Hematology · doi:10.1182/asheducation-2004.1.80 · Cited by 273
Ribera, J.-M., Oriol, A., Sanz, M.-A., Tormo, M., Fernández-Abellán, P., del Potro, E., Abella, E., Bueno, J., Parody, R., Bastida, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.7265 · Cited by 263
Kirstetter, P., Schuster, M. B., Bereshchenko, O., Moore, S., Dvinge, H., Kurz, E., Theilgaard-Mönch, K., Månsson, R., Pedersen, T. Å., Pabst, T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.008 · Cited by 251
Acquired copy number alterations in adult acute myeloid leukemia genomes
Walter, M. J., Payton, J. E., Ries, R. E., Shannon, W. D., Deshmukh, H., Zhao, Y., Baty, J., Heath, S., Westervelt, P., Watson, M. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903091106 · Cited by 246
Veerman, A. J., Kamps, W. A., van den Berg, H., van den Berg, E., Bökkerink, J. P., Bruin, M. C., van den Heuvel-Eibrink, M. M., Korbijn, C. M., Korthof, E. T., van der Pal, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70228-1 · Cited by 245
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
Pratz, K. W., Sato, T., Murphy, K. M., Stine, A., Rajkhowa, T., & Levis, M. (2010) · Blood · doi:10.1182/blood-2009-09-242859 · Cited by 242
Wagner, K., Damm, F., Göhring, G., Görlich, K., Heuser, M., Schäfer, I., Ottmann, O., Lübbert, M., Heit, W., Kanz, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6899 · Cited by 241
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia
Pui, C.-H., & Jeha, S. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2240 · Cited by 236
Self-citationSalzer, W. L., Devidas, M., Carroll, W. L., Winick, N., Pullen, J., Hunger, S. P., & Camitta, B. A. (2010) · Leukemia · doi:10.1038/leu.2009.261 · Cited by 235
Self-citationPulte, D., Gondos, A., & Brenner, H. (2009) · Blood · doi:10.1182/blood-2008-06-164863 · Cited by 234
Burnett, A. K., Hills, R. K., Milligan, D. W., Goldstone, A. H., Prentice, A. G., McMullin, M., Duncombe, A. S., Gibson, B. E. S., & Wheatley, K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9088 · Cited by 230
Cario, G., Zimmermann, M., Romey, R., Gesk, S., Vater, I., Harbott, J., Schrauder, A., Moericke, A., Izraeli, S., Akasaka, T., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256131 · Cited by 225
The incidence and clinical significance of nucleophosmin mutations in childhood AML
Brown, P., McIntyre, E., Rau, R., Meshinchi, S., Lacayo, N., Dahl, G., Alonzo, T. A., Chang, M., Arceci, R. J., & Small, D. (2007) · Blood · doi:10.1182/blood-2007-02-076604 · Cited by 216
Self-citationYang, J. J. (2009) · JAMA · doi:10.1001/jama.2009.7 · Cited by 216
Ho, P. A., Alonzo, T. A., Gerbing, R. B., Pollard, J., Stirewalt, D. L., Hurwitz, C., Heerema, N. A., Hirsch, B., Raimondi, S. C., Lange, B., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184747 · Cited by 215
Self-citationChou, W.-C., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Ko, B.-S., Wu, S.-J., Huang, S.-Y., Hsu, S.-C., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253070 · Cited by 204
Treatment of Childhood Acute Lymphoblastic Leukemia
Stanulla, M., & Schrappe, M. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.007 · Cited by 202
Wouters, B. J., Jordà, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A. J., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073486 · Cited by 199
Mitchell, C., Richards, S., Harrison, C. J., & Eden, T. (2010) · Leukemia · doi:10.1038/leu.2009.256 · Cited by 198
Yang, J. J., Bhojwani, D., Yang, W., Cai, X., Stocco, G., Crews, K., Wang, J., Morrison, D., Devidas, M., Hunger, S. P., et al. (2008) · Blood · doi:10.1182/blood-2008-06-165027 · Cited by 194
Self-citationPrognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia
Thol, F., Damm, F., Wagner, K., Göhring, G., Schlegelberger, B., Hoelzer, D., Lübbert, M., Heit, W., Kanz, L., Schlimok, G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-272146 · Cited by 186
Estey, E. H., Giles, F. J., Beran, M., O'Brien, S., Pierce, S. A., Faderl, S. H., Cortes, J. E., & Kantarjian, H. M. (2002) · Blood · doi:10.1182/blood-2001-12-0174 · Cited by 177
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
Radtke, I., Mullighan, C. G., Ishii, M., Su, X., Cheng, J., Ma, J., Ganti, R., Cai, Z., Goorha, S., Pounds, S. B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903142106 · Cited by 177
Stumpel, D. J. P. M., Schneider, P., Roon, E. H. J. V., Boer, J. M., Lorenzo, P. D., Valsecchi, M. G., de Menezes, R. X., Pieters, R., & Stam, R. W. (2009) · Blood · doi:10.1182/blood-2009-06-227660 · Cited by 169
Adès, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Stoppa, A. M., Lamy, T., Rigal-Huguet, F., Vekhoff, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1596 · Cited by 169
Ravindranath, Y., Chang, M., Steuber, C. P., Becton, D., Dahl, G., Civin, C., Camitta, B., Carroll, A., Raimondi, S. C., Weinstein, H. J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403927 · Cited by 167
Haferlach, C., Mecucci, C., Schnittger, S., Kohlmann, A., Mancini, M., Cuneo, A., Testoni, N., Rege-Cambrin, G., Santucci, A., Vignetti, M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197871 · Cited by 167
Hollink, I. H. I. M., Zwaan, C. M., Zimmermann, M., Arentsen-Peters, T. C. J. M., Pieters, R., Cloos, J., Kaspers, G. J. L., de Graaf, S. S. N., Harbott, J., Creutzig, U., et al. (2009) · Leukemia · doi:10.1038/leu.2008.313 · Cited by 166
Storring, J. M., Minden, M. D., Kao, S., Gupta, V. K., Schuh, A. C., Schimmer, A. D., Yee, K. W. L., Kamel‐Reid, S., Chang, H., Lipton, J. H., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07712.x · Cited by 153
van Grotel, M., Meijerink, J. P. P., van Wering, E. R., Langerak, A. W., Beverloo, H. B., Buijs-Gladdines, J. G. C. A. M., Burger, N. B., Passier, M., Lieshout, E. M. M. V., Kamps, W. A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404957 · Cited by 150
Improved Prognosis for Older Adolescents With Acute Lymphoblastic Leukemia
Pui, C., Pei, D., Campana, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Coustan‐Smith, E., Jeha, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0325 · Cited by 139
Self-citationNachman, J. B., La, M., Hunger, S. P., Heerema, N. A., Gaynon, P. S., Hastings, C. A., Mattano, L. A., Sather, H. N., Devidas, M., Freyer, D. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8959 · Cited by 138
de Botton, S., Fawaz, A., Chevret, S., Dombret, H., Thomas, X., Sanz, M. Á., Guerci‐Bresler, A., Miguel, J. F. S., de la Serna, J., Stoppa, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.127 · Cited by 136
Liedtke, M., & Cleary, M. L. (2009) · Blood · doi:10.1182/blood-2008-12-197061 · Cited by 135
Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy
de Botton, S., Coiteux, V., Chevret, S., Rayón, C., VILMER, E., Sanz, M. Á., de la Serna, J., Philippe, N., Baruchel, A., Leverger, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.008 · Cited by 130
Schafer, E. S., Irizarry, R. A., Negi, S., McIntyre, E., Small, D., Figueroa, M. E., Melnick, A. M., & Brown, P. A. (2010) · Blood · doi:10.1182/blood-2009-09-243634 · Cited by 122
Bernstein, J., Dastugue, N., Haas, O., Harbott, J., Heere, N., Huret, J. L., Landman‐Parker, J., Beau, M. M. L., Leonard, C. A., Mann, G., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401639 · Cited by 121
Smith, F. O., Alonzo, T. A., Gerbing, R. B., Woods, W. G., Arceci, R. J., & for the Children's Cancer Group (2005) · Leukemia · doi:10.1038/sj.leu.2403925 · Cited by 120
Self-citationSegmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia
Raghavan, M., Smith, L., Lillington, D. M., Chaplin, T., Kakkas, Ι., Molloy, G. Y., Chelala, C., Cazier, J., Cavenagh, J. D., Fitzgibbon, J., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132431 · Cited by 114
Kamps, W. A., Bruin, K. M. V. D. P., Veerman, A. J. P., Fiocco, M. F., Bierings, M., & Pieters, R. (2009) · Leukemia · doi:10.1038/leu.2009.258 · Cited by 114
Attarbaschi, A., Mann, G., Panzer‐Grümayer, R., Röttgers, S., Steiner, M., König, M., Csinady, E., Dworzak, M. N., Seidel, M. G., Janousek, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1117 · Cited by 111
Brown, P. A., Levis, M. J., McIntyre, E., Griesemer, M., & Small, D. (2006) · Leukemia · doi:10.1038/sj.leu.2404277 · Cited by 103
Ho, P. A., Alonzo, T. A., Kopecky, K. J., Miller, K. L., Kuhn, J., Zeng, R., Gerbing, R. B., Raimondi, S., Hirsch, B. A., Oehler, V. G., et al. (2010) · Leukemia · doi:10.1038/leu.2010.56 · Cited by 102
Self-citationA decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Wouters, B. J., Löwenberg, B., & Delwel, R. (2008) · Blood · doi:10.1182/blood-2008-04-153239 · Cited by 97
Dignat‐George, F., Sabatier, F., Blann, A. D., & Woywodt, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7677 · Cited by 96
Nanri, T., Matsuno, N., Kawakita, T., Suzushima, H., Kawano, F., Mitsuya, H., & Asou, N. (2005) · Leukemia · doi:10.1038/sj.leu.2403803 · Cited by 94
Thirugnanam, R., George, B., Chendamarai, E., Lakshmi, K. M., Balasubramanian, P., Viswabandya, A., Srivastava, A., Chandy, M., & Mathews, V. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.07.010 · Cited by 94
Liang, D.-C., Yang, C.-W., Lin, D.-T., Hung, I., Lin, K.-H., Chen, J.-S., Hsiao, C., Chang, T.-T., Peng, C.-T., Mt, L., et al. (2009) · Leukemia · doi:10.1038/leu.2009.248 · Cited by 94
Yang, W., Treviño, L. R., Yang, J. J., Scheet, P. A., Pui, C., We, E., & Relling, M. V. (2010) · Leukemia · doi:10.1038/leu.2009.277 · Cited by 94
Self-citationFigueroa, M. E., Wouters, B. J., Skrabanek, L. A., Glass, J. L., Li, Y., Erpelinck-Verschueren, C. A. J., Langerak, A. W., Löwenberg, B., Fazzari, M. J., Greally, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172387 · Cited by 91
Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia
Gupta, M., Raghavan, M., Gale, R. E., Chelala, C., Allen, C. G., Molloy, G. Y., Chaplin, T., Linch, D. C., Cazier, J., & Young, B. D. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20573 · Cited by 90
Ho, P. A., Zeng, R., Alonzo, T. A., Gerbing, R. B., Miller, K. L., Pollard, J. A., Stirewalt, D. L., Heerema, N. A., Raimondi, S. C., Hirsch, B. A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268953 · Cited by 90
Self-citationAcute myeloid leukemia and Down Syndrome evolution of modern therapy?state of the art review
Gamis, A. S. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20207 · Cited by 87
Crispino, J. D. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20066 · Cited by 87
O'Brien, M. M., Taub, J. W., Chang, M. N., Massey, G. V., Stine, K. C., Raimondi, S. C., Becton, D. L., Ravindranath, Y., & Dahl, G. V. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2209 · Cited by 85
Shih, L.-Y., Liang, D.-C., Huang, C.-F., Chang, Y.-T., Lai, C.-L., Lin, T., Yang, C.-P., Hung, I., Liu, H., Jaing, T.-H., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404995 · Cited by 79
New Genetic Abnormalities and Treatment Response in Acute Lymphoblastic Leukemia
Meijerink, J. P. P., den Boer, M. L., & Pieters, R. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.006 · Cited by 65
Abundant anti‐apoptotic BCL‐2 is a molecular target in leukaemias with t(4;11) translocation
Robinson, B. W., Behling, K. C., Gupta, M., Zhang, A. Y., Moore, J. S., Bantly, A. D., Willman, C. L., Carroll, A. J., Adamson, P. C., Barrett, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07100.x · Cited by 63
Weisser, M., Haferlach, C., Hiddemann, W., & Schnittger, S. (2007) · Leukemia · doi:10.1038/sj.leu.2404659 · Cited by 61
Schrappe, M., Zimmermann, M., Möricke, A., Mann, G., Valsecchi, M. G., Bartram, C. R., Biondi, A., Panzer‐Grümayer, R., Schrauder, A., Locatelli, F., et al. (2008) · Blood · doi:10.1182/blood.v112.11.7.7 · Cited by 47
Clinical implications of molecular genetic aberrations in acute myeloid leukemia
Scholl, S., Fricke, H., Sayer, H. G., & Höffken, K. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0524-x · Cited by 33
Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin.
Lo‐Coco, F., Ammatuna, E., & Noguera, N. I. (2006) · PubMed · Cited by 30
Cited by
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Self-citationSurvivors of childhood and adolescent cancer: life-long risks and responsibilities
Robison, L. L., & Hudson, M. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3634 · Cited by 857
Creutzig, U., van den Heuvel-Eibrink, M. M., Gibson, B., Dworzak, M. N., Adachi, S., de Bont, E., Harbott, J., Hasle, H., Johnston, D., Kinoshita, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-362608 · Cited by 577
Self-citationPerspectives on the causes of childhood leukemia
Wiemels, J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.01.007 · Cited by 513
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
Self-citation
Metadata
- Authors
- Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-02-10
- Volume
- 29
- Issue
- 5
- Pages
- 551-565
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2141869972
- Cited by
- 842
- References
- 119
- FWCI
- 78.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.